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Context: Discriminating adipose and glandular tissue is challenging when clinically assessing 
breast development. Ultrasound facilitates staging of pubertal breast maturation (US B), but has 
not been systematically compared to Tanner breast (Tanner B) staging, and no normative data 
have been reported.
Objective: To present normative references for US B along with references for Tanner B, pubic 
hair (PH), and menarche.
Design, Setting, and Participants: A cross-sectional sample of 703 healthy girls aged 6 to 
16 years were examined.
Main Outcome Measures: Breast development was determined with US B and Tanner B staging. 
Tanner PH and menarcheal status were recorded. The age distributions of entry in US B, Tanner 
B, and PH stages and menarche were estimated with generalized linear and generalized additive 
models with a probit link. Method agreement was tested with weighted Cohen’s kappa.
Results: The median (±2SD) ages for thelarche, US B2 and Tanner B2, were 10.2 (7.7, 12.8) and 10.4 
(8.0, 12.7) years. The median (±2SD) ages at Tanner PH2 and menarche were 10.9 (8.5, 13.3) and 
12.7 (11.0, 16.2) years. Cohen’s kappa of agreement (95% confidence interval) between US B and 
Tanner B was 0.87 (0.85–0.88). When the methods disagreed, US B was usually more advanced.
Conclusion: Thelarche occurred at a slightly younger age when assessed with ultrasound compared 
to clinical Tanner staging, although the 2 methods had a very good agreement when determining 
pubertal breast maturation. A significant decrease of 2.8 months in age at menarche was observed 
during the past decade in Norwegian girls. (J Clin Endocrinol Metab 105: 1–9, 2020)
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B reast development in girls is usually defined clinic-ally by the 5-stage scale as described by Marshall 
and Tanner in 1969 (1,2). The Tanner breast (Tanner B) 
scale ranges from B1 (prepubertal) to B5 (mature), in 
which stage B2 marks the first appearance of glandular 
breast tissue (thelarche) and thus the start of central pu-
berty. Clinical breast staging relies on visual inspection 
and palpation to distinguish the glandular breast tissue 
from adipose tissue, but this approach is often perceived 
as challenging. With ultrasound (US), we, and others, 
have been able to identify distinctive breast develop-
mental stages based on changes in the appearance and 
relative amount of glandular, adipose and fibrous tissues 
(3–5). Despite being a promising method, US staging of 
the breast has not yet been systematically compared 
with clinical Tanner B staging in a large developmen-
tally diverse sample, and no normative references have 
yet been published.
In Norway and other northern European countries, 
only marginal changes in age at menarche have been 
reported during the last decades (6–10). However, data 
from Denmark and the United States have shown that 
the onset of breast development might be advancing 
toward younger ages (7,11,12). A  worldwide secular 
trend toward younger ages at thelarche according to 
race/ethnicity and geography was also shown in a re-
cent systematic review (13). Accordingly, these studies 
suggest an asymmetrical secular trend of earlier breast 
development, while age at menarche remains more 
stable. Early puberty, and early menarche in particular, 
have been associated with increased all-cause mortality 
(14), a higher risk of breast cancer (15), cardiovascular 
disease (16), and mental health problems (17). It has 
been suggested that this secular trend may be caused by 
overweight or endocrine disrupting chemicals (18,19).
The present study is a part of the Bergen Growth 
Study 2 (BGS 2), which is the first large-scale pubertal 
reference study conducted in Norway. In addition to data 
on menarche and traditional Tanner B and pubic hair 
(PH) stages, we collected data on breast developmental 
stage assessed with US (US B) as a novel methodological 
approach. The aim of the current work was to provide 
descriptive reference ranges for these phenotypic traits in 
a large sample of contemporary girls living in Norway, 
to compare both methods of staging breast development, 
and to assess recent changes in age at menarche.
Materials and Methods
Study design and participants
A total of 1349 girls between 6 and 16 years of age from 
6 randomly selected public schools in Bergen municipality, 
Norway, were invited to participate. Bergen is the second lar-
gest city in Norway and the demographic profile and living 
conditions are very similar to those in the country at large 
(20). Parental consent was received prior to examination from 
678 girls (50.3%) from January to June 2016. The partici-
pation rates varied with age, from 52.1% before 12 years to 
43.4% above 13  years, and between schools, from 29.1% 
to 59.4%. In addition, data on breast development from 57 
girls examined in February 2017 for a reliability study were 
included in the analysis. Details from this study have been 
published previously (5). A  parental questionnaire with in-
formation on chronic illness, parental origin, socioeconomic 
status, and menarche was obtained from 482 (68.6%) girls. 
Five girls were absent on the day of examination, and 27 
girls were excluded due to a disease likely to affect growth or 
maturation, leaving 703 girls eligible for the analysis. Of 466 
girls with known origin of both parents, 374 (80.2%) were 
Norwegian, 408 (88.9%) European, and 51 girls (11.1%) had 
1 or 2 non-European parents, mostly from Asia (n = 30), Africa 
(n = 12), or South America (n = 7) (Supplementary Table 1, all 
supplementary materials and figures are located in a digital 
data repository (21)). The analyses are based on all girls, re-
gardless of their origin. The highest educational level of both 
parents was used as an indicator of socioeconomic status. This 
level was classified as primary education (9 years of school), 
secondary education (12 years of school), or higher education 
(college degree). Demographics of the study populations from 
Bergen Growth Study 1 (BGS 1) and BGS 2 are summarized in 
Supplementary Table 1 (21).
The median (range) age in the final sample was 10.7 
(6.1–16.2) years. Due to missing data (menarche was not re-
corded in 3 girls, 3 girls declined examination of the breast, and 
81 declined examination of PH, and the US image could not be 
retrieved for off-site scoring in 4 girls), the pubertal references 
are based on 696 observations of US B, 700 of Tanner B, and 
643 of menarche. Data on the Tanner PH stage were available 
for 372 girls as further explained in the following discussion.
Examinations
The girls were examined during school hours. All examin-
ations were performed by a single female nurse (ISB), who was 
trained in US staging of breast development by an experienced 
pediatric radiologist (KR) before and at the start of the ac-
tual data collection. Pubertal development was assessed with 
the girl in the supine position. The US examinations were per-
formed using a Sonosite Edge machine (Fujifilm SonoSite, US) 
with a 15–6 MHz (5 cm) linear probe. Based on a standard 
mid-sagittal section, breast development was scored on a scale 
from 0 to 5, consistent with our previously published descrip-
tions (5). US breast staging was conducted based on radio-
logic characteristics (Supplementary Figure 1, (21)). In brief, a 
small, hypoechoic retro-areolar mass is scored as US B0, while 
a hyperechoic area (with or without a small hypoechoic mass) 
is US B1. Both US B0 and US B1 are considered prepubertal. 
US B2 is characterized by the presence of hyperechoic retro-
areolar glandular breast tissue with a round or star-shaped 
hypoechoic center. This stage is assumed to mark the start of 
puberty (3,5). US B3 is characterized by a larger, spider-shaped 
hypoechoic center, becoming increasingly roundish in US B4 
(5). The mature US B5 is characterized by heterogeneous glan-
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US B2 to B4. The left breast was examined according to the 
protocol. Due to logistic reasons, the US stage was determined 
at a later time in 166 girls, by the same examiner, based on 
the standardized US images. This was done to avoid the girls 
becoming uncomfortable due to prolonged exposure. Based 
on a reassessment of 120 saved images, we determined that 
this had little impact on the results. Intra- and inter-observer 
agreement of US B staging was determined in an additional 
study of 57 girls (5). Cohen’s kappa was estimated at 0.84 and 
0.71, respectively, which is commonly considered good to very 
good agreement (22).
The development of the breasts and PH was clinically 
scored on a scale from 1 to 5 (B1–B5 and PH1–PH5) ac-
cording to the method described by Tanner (1), which is based 
on a visual inspection, although palpation of the breast was 
included in this procedure. Pubertal onset is defined as Tanner 
B2, which is characterized by the visual and/or palpable ap-
pearance of glandular tissue. The left breast was always exam-
ined, however, in 3 cases the right breast was found more 
advanced according to Tanner B staging and therefore used in 
the references (Tanner B staging recorded additionally on the 
right side in 453 girls). A subsample of 453 girls were asked 
if the examiner could assess the Tanner PH by visual inspec-
tion, to which 372 (82.1%) assented. Because of assumed time 
constrains, Tanner B staging of the right breast and Tanner 
PH staging were not included in the protocol at the start of 
the study but were only added and systematically recorded 
from February 22 until the end of the data collection. Tanner 
PH2 marks the first appearance of PH (1,2). All participants 
were asked if they had experienced their first menstruation 
(menarche) and the month/year, if applicable. Missing data on 
menarche were completed with data from the parental ques-
tionnaire for 16 girls. Two girls above 15 years of age were 
encouraged to see their general practitioner due to primary 
amenorrhea.
Height was measured in the standing position with a 
Harpenden Portable Stadiometer (Holtain Ltd Crosswell, UK) 
and recorded to the nearest 0.1 cm. Weight was measured in 
light clothing with an electronic scale (Tanita MC-780MA, 
Tanita Corp. of America, Inc. Illinois, US) with a precision of 
0.1  kg. Body mass index (BMI) was calculated by dividing 
weight (in kg) by the square of height (in meters). The BMI 
was available for 645 (91.7%) girls of whom 14.6% were 
overweight (including obesity) and 7.3% were underweight 
according to the definitions from the International Obesity 
Task Force (23,24).
Statistical analysis
Age at menarche or entry into a certain puberty stage 
was estimated from age and pubertal status of the girls with 
a generalized linear model (probit regression) and with a 
nonparametric generalized additive model (GAM) for binary 
outcomes with probit link. The methods differ by the assump-
tion of a normal age distribution (probit) or not (GAM). The 
probit and GAM curves were estimated for each consecutive 
stage separately. The degree of smoothing of the GAM was 
determined by generalized cross-validation and models were 
checked with diagnostic plots using the mgcv package (25) 
in R version 3.5 (R Foundation for Statistical Computing, 
Vienna, Austria, 2018). Primarily, the median, percentiles, and 
equivalent z-scores of age at entry from the nonparametric 
additive model are reported in the tables. In addition, we re-
port the mean and standard deviation (SD) from the para-
metric probit models to allow a comparison with data from 
other studies. In addition to reference data based on all eli-
gible girls, we estimated age at menarche and transition to 
US B2, Tanner B2, and Tanner PH2 in the subgroup of girls 
with a documented Norwegian or non-Norwegian origin. The 
statistical significance of differences between Norwegian and 
non-Norwegian girls was tested with logistic regression using 
age as a covariate and origin (Norwegian, non-Norwegian) as 
the variable of interest. This analysis was limited to girls with 
a documented origin only.
Agreement between US B and Tanner B staging was ana-
lyzed with simple Cohen’s kappa and Cohen’s kappa test with 
linear weights. The kappa statistic gives a coefficient between 
0 (no agreement) and 1 (perfect agreement) (22). For these 
comparisons, the US B0 and B1 stages were collapsed into a 
single prepubertal stage. Separate analysis of agreement and 
percentage concordance between the methods were done for 
girls with normal weight and overweight (including obesity).
To investigate if age at menarche had advanced in the 
Bergen municipality since the first Bergen Growth Study 
(BGS 1), conducted in 2003 to 2006, we compared girls with 
a documented Norwegian or Nordic (1.5%) background 
in both studies to avoid interference from demographic 
changes in the population. Details from BGS 1 have been 
published elsewhere (10). In brief, girls from 8 to 15.5 years 
(n  =  1481) were asked if they had experienced their me-
narche, and this was the only pubertal marker recorded in 
BGS 1. The occurrence of menarche was compared between 
both studies with logistic regression using age, BMI z-score, 
and parental educational level as covariates. Logistic re-
gression, and agreement analyses were done in Statistical 
Package for Social Sciences (SPSS version 24) and R (ver-
sion 3.5).
Ethical considerations
The project was approved by the Regional Committee for 
Medical and Health Research Ethics West Norway (number 
2015/128/REK Vest). Written informed consent was obtained 
from a parent or legal guardian of each participant and also 
from the participants 12 years and older. All girls received age-
appropriate information in writing and orally by the study 
nurse ahead of participation. Assent from the participant was 
an additional requirement for inclusion. All participants re-
ceived a cinema ticket for their collaboration.
Results
The medians and equivalent z-scores, means, and SD 
for age at entry into consecutive US B, Tanner B and 
PH stages, and menarche are presented in Table  1. 
Traditional age percentiles of all pubertal markers are 
provided in Supplemental Table 2 (21). Reference quan-
tiles were calculated nonparametrically from the cu-
mulative distribution estimated with a GAM, which in 
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The distribution of age at onset of breast develop-
ment measured with US was slightly ahead of the Tanner 
method. However, the opposite was true for the higher 
maturational stages, where the age at transition with the 
Tanner method was ahead of the assessment with US. 
The mean age (SD) of thelarche was 10.2 (1.3) years 
with US (US B2), and 10.4 (1.2) years with the Tanner 
method (Tanner B2). The lower end of the normal range 
defined by a z-score of –2 SD was 7.7 and 8.0 years, 
respectively, while the corresponding upper limits were 
12.8 and 12.7 years.
The breast developmental stage assessed with US 
and the Tanner method was concordant in 551 of 695 
(79.3%) girls for whom both assessments were avail-
able (kappa  =  0.87; 95% confidence interval [CI]; 
0.85–0.89) (Table  2). When dichotomizing the breast 
developmental stage into thelarche or not thelarche, 
the agreement was very good (kappa = 0.94; 95% CI; 
0.91–0.96). US identified breast development (US B 
≥2) in 18 girls in whom the mammary gland was not 
palpable (corresponding to Tanner B1). Opposite, three 
girls had clinical signs of pubertal breast development 
(Tanner ≥B2) with no glandular breast tissue visible on 
US (US B0 or US B1). The kappa coefficients when com-
paring the 2 methods were 0.88 (95% CI 0.86–0.91) 
and 0.85 (95% CI: 0.79–0.90) for girls with normal 
and overweight/obesity, respectively. Full concordance 
between US B and Tanner B staging was found in 81.6% 
and 73.4% of girls with normal weight and overweight/
obesity, respectively.
Pubic hair development (Tanner ≥PH2) was ob-
served in 182 of 372 (48.9%) girls. The mean (SD) age 
at Tanner PH2 was estimated as 10.9 (1.2) years. The 
age distribution of each Tanner PH stage was close to 
normal (Fig. 1C).
In total, 193 of 643 (30.0%) girls had experienced 
menarche. The median (±2 SD) age at menarche was 
12.7 (11.0–16.2) years. This is 2.5 years after thelarche 
according to the US method (US B2) and 2.3 years after 
thelarche according to the Tanner method (B2). A com-
parison of the probit model and the GAM indicated a 
positive skewness in the distribution of age at menarche 
(Fig. 1D).
The onset of all pubertal markers occurred earlier 
in girls with a non-Norwegian origin (n  =  92) com-
pared to girls with two parents of Norwegian origin 
(n  =  374), in the subset of girls with known origin 
(74%) (Supplemental Table 3 (21)). The difference was 
only statistically significant for the start of breast de-
velopment according to US (P  <  .05). Compared to 
girls from BGS 1, mean (SD) age at menarche in girls of 
Norwegian, including Nordic, origin had significantly 
declined from 13.3 (1.7) years (not previously pub-
lished) in 2006 to 13.1 (1.2) years in 2016 (P < 0.05). 
Table 1. Age References for Breast Development, Pubic Hair and Menarche: Median and Distribution (–2, 
–1, 1, 2 SD) of the Age (in Years) at Attainment of the Specified Stage
Generalized Additive Model   
Age at Attainment Probit
Pubertal marker –2 SD –1 SD Median 1 SD 2 SD Mean (SD) age
Breast (ultrasound)       
 US B1 NA 5.6a 8.3 10.7 12.4 8.3 (2.2)
 S B2 7.7 8.9 10.2 11.5 12.8 10.2 (1.3)
 US B3 9.1 10.3 11.5 12.7 13.9 11.5 (1.2)
 US B4 10.4 11.3 12.3 13.9 NA 12.7 (1.5)
 US B5 11.3 12.7 15.9 NA NA 15.3 (2.3)
Breast (Tanner)       
 B2 8.0 9.2 10.4 11.6 12.7 10.4 (1.2)
 B3 9.5 10.4 11.4 12.5 13.8 11.5 (1.1)
 B4 10.7 11.6 12.5 13.8 NA 12.8 (1.3)
 B5 11.1 12.3 14.7 NA NA 14.8 (2.2)
Pubic Hair (Tanner)   
 PH2 8.5 9.7 10.9 12.1 13.3 10.9 (1.2)
 PH3 9.7 10.9 11.9 12.9 13.7 11.9 (1.1)
 PH4 10.5 11.8 13.1 14.4 15.7 13.1 (1.3)
 PH5 11.4 13.0 15.1 NA NA 15.1 (1.9)
Menarche 11.0 11.7 12.7 14.1 16.2 12.9 (1.2)
Distribution of age at entry in consecutive stages of breast development measured with ultrasound (US B; n = 696), breast development according to 
Tanner B (n = 700), Pubic hair (PH) according to Tanner (n = 372) and menarche (n = 643) in 6- to 16-year-old healthy girls in Bergen, Norway. Me-
dian age and ±1 or 2 reference limits were estimated with nonparametric generalized additive models. Mean (SD) ages were estimated with probit 
regression. 
Abbreviations: B, breast; NA, not applicable (outside the data range); PH, pubic hair; SD, standard deviation; US B, ultrasound-based breast stage.
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Figure 1. Age reference curves. Age distribution of pubertal development in 6- to 16-year-old girls living in Norway. A: Stages of breast 
development with ultrasound (n = 696); B: Breast development stage by Tanner stage (n = 700); C: Pubic hair (PH) according to Tanner (n = 372); 
D: Menarche (n = 643). Black lines show the parametric probit model, assuming a Gaussian distribution of the age at transition; grey lines show 
the corresponding curves of the nonparametric generalized additive model with a probit link; connected dots show the cumulative proportion of 
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The difference in occurrence of menarche between both 
studies remained statistically significant (odds ratio 2.0; 
95% CI 1.1–3.6; P  =  .016), when accounting for the 
BMI z-score and parental educational level. Parental 
education was not retained in the final models because it 
was not significantly associated with menarche in either 
study. The age distribution in both studies is shown in 
Supplementary Figure 2 (21) for all girls in the study and 
in Supplementary Figure 3 (21) for girls of Norwegian/
Nordic origin.
Discussion
In this study, we describe female pubertal develop-
ment using a large contemporary sample of healthy 
girls living in Norway. The results are summarized as 
age percentiles, which can serve as normative reference 
intervals for pubertal milestones in the Norwegian and 
other comparable populations. Up-to-date references 
are important to support clinical decision-making. In 
addition to the traditional Tanner stages, we have also 
documented breast development based on US examin-
ation of glandular breast tissue. Our results show a high 
degree of concordance between the 2 methods, but the 
start of breast development is detected almost 2 months 
earlier with US staging. Finally, our results indicate that 
there might be an ongoing decrease in the age at me-
narche in the Norwegian population.
The principle of assessing breast development with 
US examination of the mammary gland has been pro-
posed by several authors (4,5,26–28), but US staging 
of breast development was not yet compared with clin-
ical staging in a large sample of healthy pubescent girls, 
and no reference data were available. The 4 studies that 
could be identified were small (<80 subjects) or based 
on a heterogeneous clinical sample (4,26–28). US sta-
ging is a promising technique with a good intra- and 
inter-observer reliability (5) that may overcome several 
known limitations of the visual and palpatory method 
described by Tanner. In the present study, we have 
shown that both methods agree well with each other 
in a large sample of girls at various stages of their de-
velopment, also when stratifying by weight category. 
The kappa statistic showed good agreement over all five 
stages and very good agreement when girls were clas-
sified as having thelarche or not. The biggest discrep-
ancy was observed between Tanner B5 and US staging, 
but in most cases, this difference was 1 stage only. This 
may be due to the statistical model because only about 
half of the girls have reached stage 5 by the end of the 
age range of girls included in the study (differences are 
smaller at –1 or –2 SD) but could also reflect a discrep-
ancy between the size of the breast and maturation of 
the gland as visualized with US or reflect an overlap of 
the characteristics of stages 4 and 5 with the Tanner and 
US methods.
However, the latter comparison also indicated that the 
US method is probably more sensitive to pick up changes 
that are consistent with the start of pubertal breast de-
velopment. In addition, US examination identifies two 
distinct developmental stages (denoted as US B0 and US 
B1) in girls who are prepubertal (B1) according to the 
Tanner method. This has not been acknowledged in pre-
vious studies by other authors (5). Both these stages are 
considered by us as prepubertal and future research will 
indicate to what extent they correlate with physiological 
and hormonal changes. For the comparison of the US and 
Tanner methods both prepubertal stages were merged.
The mean age at thelarche according to the Tanner 
method (B2) was 10.4 years with an SD of 1.2 years. While 
no historical data are available for the Norwegian popula-
tion, other studies reported a substantial decline in onset of 
breast development (Tanner B2) from 10.9 years in 1993 to 
9.9 years in 2008 in Danish girls living in the Copenhagen 
area (7). However, a more recent population-based longi-
tudinal study of self-reported onset of breast development 
found a mean age at thelarche of 10.4  years, which is 
more comparable to our findings (29). A declining age at 
Table 2. Distribution of Breast Development with Ultrasound and Tanner Staging
Breast Development With Ultrasound
Tanner stage US B0 US B1 US B2 US B3 US B4 US B5 Total
B1 166 129 18 0 0 0 313
B2 1 2 63 12 2 0 80
B3 0 0 13 43 25 2 83
B4 0 0 0 15 77 16 108
B5 0 0 0 5 33 73 111
Total 167 131 94 75 137 91 695
Agreement of the breast developmental stage according to Tanner (B1 to B5) and ultrasound examination (US B0 to B5) in 695 6- to 16-year-old 
girls in Bergen, Norway. US B0 and US B1 and Tanner B1 are prepubertal stages; stages US B0 and US B1 are merged for the analysis of method 
agreement.









niversitetsbiblioteket i Bergen user on 01 M
ay 2020
doi:10.1210/clinem/dgaa107 https://academic.oup.com/jcem  7
thelarche has also been reported in the United States (11,30) 
and in the United Kingdom (9), but studies from Belgium (6) 
and the Netherlands(31) reported a mean age at thelarche 
of 10.7 years, without an apparent trend toward younger 
ages. The lower reference limit (–2 SD) for age at attaining 
Tanner B2 was 8.0 years in the current study. Overall, these 
findings suggest that the onset of breast development in 
Norwegian girls is neither earlier nor later when compared 
to other northern European countries and that the current 
age limit of precocious puberty in girls (ie, start of breast de-
velopment before 8 years) can be maintained, as is the case 
in other countries (6,32). Likewise, we reported a mean (SD) 
age of the start of PH development (Tanner PH2) of 10.9 
(1.2) years, which corresponds well with the mean ages of 
11.0 to 11.1 years reported in northern European popula-
tions (6,7,31).
Mean age at menarche fluctuates within a narrow 
range from 12.9 to 13.1  years in most studies from 
northern Europe (6,7,9,29,33). Although age at me-
narche has been remarkably stable for more than half 
a century, a small but statistically significant decline has 
been reported in Denmark and the Netherlands (0.3 and 
0.1 years, respectively) (7,33). A recent study from the 
United States reported an overall median age at menarche 
of 12.3 years and in white girls 12.7 years (12), which is 
only a modest change from a previous U.S. study where 
the age at menarche in white girls was 12.9 years (11). 
In the current study, we found a median age at menarche 
of 12.7 years, which is in line with the white girls from 
the United States, but earlier than the cited northern 
European studies. However, we previously reported an 
overall median age at menarche of 13.1 years in BGS 1 
from 2006 (10). The age at menarche in Norway has 
been stable just above 13 years during the last 50 years 
(10,34). To rule out possible interference from recent 
changes in the composition of the target population 
such as origin, BMI, and socioeconomic background, 
we compared a subsample of girls with a documented 
Norwegian origin from both studies and included BMI 
and parental educational level in the analysis. Parental 
education was not significantly associated with age at 
menarche, but there was a significant effect of the BMI 
as was documented before (10). The statistically signifi-
cant decrease with 2.8 months in age at menarche since 
2006 was however not affected by the inclusion of the 
BMI z-score in the models because the BMI distribution 
was highly comparable in both studies. An increased ex-
posure to endocrine disruptive chemicals remains a pos-
sible hypothesis, to which we cannot offer a conclusive 
answer in the current analysis (19). Given the potential 
importance of this finding, we believe it should be con-
firmed in a larger population-based study.
For the descriptive reference ranges of menarche and 
secondary sexual characteristics we have included all girls 
regardless their origin in the reference sample because their 
impact on the reference limits is relatively small from a 
clinical perspective, and implementation of a single ref-
erence might be more feasible. Establishing and adapting 
reference curves to fit an increasingly demographically 
heterogenic composition where growth and puberty 
timing of the native population is different to that of im-
migrant populations remain an epidemiological challenge.
Although the BGS 2 included a large number of chil-
dren at or near puberty and covers many aspects of pu-
bertal development, some limitations should be noted. 
The schools were randomly selected and cover various 
socioeconomic conditions, but they were all situated in 
mostly urban areas of the municipality of Bergen. The 
prevalence of overweight (including obesity) of 14.6% 
in our study is slightly lower than, but still comparable 
to, data from the first Bergen growth study (17.7%) (35) 
and to data from a nationally representative sample of 
9-year-old girls (17%) (36). Including girls from different 
Norwegian regions would have increased generalizability 
but would also have introduced logistic challenges and 
could have negatively impacted the standardization of 
measurement procedures. The recruitment strategy is 
also a potential source of selection bias, that is, when 
girls with a relatively early or late puberty are more re-
luctant to participate. Our study sample is representative 
of the Norwegian population with respect to origin (37). 
Girls of non-Norwegian origin were included in the ana-
lysis since this reflects the natural variation in the target 
population. Although this increases the applicability of 
the references in the Norwegian population at large, it 
may also hamper the comparability of the data with 
other nations or future studies. For this reason, we also 
provided references based on a subsample of girls with a 
Norwegian background as supplementary material (21). 
Our knowledge about the nonparticipants is limited to 
school and grade. However, there was a slightly lesser 
participation rate in schools with a larger number of 
children with a non-Norwegian background. Increased 
nonparticipation in these schools may have been caused 
by language barriers or cultural preferences of parents.
One of the potential advantages of US staging of breast 
development relates to difficulties with Tanner staging in 
girls with obesity. We observed that the agreement and con-
cordance between the two breast staging methods were 
slightly lower among the girls with overweight and obesity 
and that the clinical assessment, Tanner B, showed a more 
mature stage compared to the US B in more cases among 
the girls with overweight than in the normal weight group 
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B2 would have been preferable to further examine the rela-
tion between US B and Tanner B around the clinical stage 
that defines pubertal onset. Another limitation is the low 
response, even though we consider the participation rate 
of 50% as relatively high for this particular type of study. 
Information on health and ethnicity were only known when 
the questionnaire was answered and returned by parents 
(69%), which may have resulted in the inclusion of some 
girls with relevant pathology unknown to us. However, the 
prevalence of such conditions was low in girls with a ques-
tionnaire available, and including or excluding them had 
little impact on the resulting estimates (data not shown).
In conclusion, we found that US and Tanner B sta-
ging are in close agreement when determining the de-
gree of pubertal breast maturation. US allows for a 
direct examination of the mammary gland and detects 
pubertal breast development slightly ahead of clinical 
Tanner B staging. Moreover, this method allows to dis-
criminate 2 distinct prepubertal stages, the clinical rele-
vance of which will be the subject of further research. 
Pubertal breast and PH development in Norwegian girls 
occur at comparable ages as in their northern European 
peers. In girls of Norwegian origin, age at menarche 
occurred at a significantly younger age than 10 years 
before. This trend toward earlier menarche merits fur-
ther investigation.
Acknowledgments
We would like to thank all the children who participated in 
Bergen Growth Study 2. We also acknowledge Magnus Rise 
Sveen for his substantial help during data collection. 
Financial Support: This study was supported by a grant 
(number 912221) from the Western Norway Regional Health 
Authority.
Additional Information
Correspondence and Reprint Requests: Ingvild Særvold 
Bruserud, Department of Clinical Science, University of 
Bergen, Haukelandsbakken 15, 5021 Bergen, Norway. E-mail: 
ingvild.servold.bruserud@helse-bergen.no.
Disclosure Summary: The authors have nothing to dis-
close.
Data Availability: Restrictions apply to the availability of 
data generated or analyzed during this study to preserve patient 
confidentiality or because they were used under license. The cor-
responding author will on request detail the restrictions and any 
conditions under which access to some data may be provided.
References
 1. Tanner  JM. Growth at Adolescence. 2nd ed. Springfield, IL: 
Thomas; 1962.
 2. Marshall  WA, Tanner  JM. Variations in pattern of pubertal 
changes in girls. Arch Dis Child. 1969;44(235):291–303.
 3. García CJ, Espinoza A, Dinamarca V, et al. Breast US in children 
and adolescents. Radiographics. 2000;20(6):1605–1612.
 4. Bruni  V, Dei  M, Deligeoroglou  E, et  al. Breast development in 
adolescent girls. Adolesc Pediatr Gynecol. 1990; 3:201–205
 5. Bruserud IS, Roelants M, Oehme NHB, et al. Ultrasound assessment 
of pubertal breast development in girls: intra- and interobserver 
agreement. Pediatr Radiol. 2018;48(11):1576–1583.
 6. Roelants  M, Hauspie  R, Hoppenbrouwers  K. References for 
growth and pubertal development from birth to 21  years in 
Flanders, Belgium. Ann Hum Biol. 2009;36(6):680–694.
 7. Aksglaede L, Sørensen K, Petersen JH, Skakkebaek NE, Juul A. 
Recent decline in age at breast development: the Copenhagen 
Puberty Study. Pediatrics. 2009;123(5):e932–e939.
 8. Juul  A, Teilmann  G, Scheike  T, et  al. Pubertal development in 
Danish children: comparison of recent European and US data. Int 
J Androl. 2006; 29:247–255; discussion 286–290
 9. Rubin C, Maisonet M, Kieszak S, et al. Timing of maturation and 
predictors of menarche in girls enrolled in a contemporary British 
cohort. Paediatr Perinat Epidemiol. 2009;23(5):492–504.
 10. Bratke H, Bruserud IS, Brannsether B, et al. Timing of menarche 
in Norwegian girls: associations with body mass index, waist cir-
cumference and skinfold thickness. BMC Pediatr. 2017;17(1):138.
 11. Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary 
sexual characteristics and menses in young girls seen in office 
practice: a study from the Pediatric Research in Office Settings 
network. Pediatrics. 1997;99(4):505–512.
 12. Biro FM, Pajak A, Wolff MS, et al. Age of menarche in a lon-
gitudinal US cohort. J Pediatr Adolesc Gynecol. 2018;31(4): 
339–345.
 13. Eckert-Lind C, Busch AS, Petersen JH, et al. Worldwide secular trends 
in age at pubertal onset assessed by breast development among 
girls: a systematic review and meta-analysis. JAMA Pediatrics 2020. 
doi:10.1001/jamapediatrics.2019.5881. [Epub ahead of print]
 14. Charalampopoulos  D, McLoughlin  A, Elks  CE, Ong  KK. Age 
at menarche and risks of all-cause and cardiovascular death: 
a systematic review and meta-analysis. Am J Epidemiol. 
2014;180(1):29–40.
 15. Collaborative Group on Hormonal Factors in Breast Cancer. 
Menarche, menopause, and breast cancer risk: individual par-
ticipant meta-analysis, including 118 964 women with breast 
cancer from 117 epidemiological studies. Lancet Oncol. 
2012;13:1141–1151.
 16. Lakshman R, Forouhi NG, Sharp SJ, et al. Early age at menarche 
associated with cardiovascular disease and mortality. J Clin 
Endocrinol Metab. 2009;94(12):4953–4960.
 17. Mendle  J, Ryan  RM, McKone  KMP. Age at menarche, de-
pression, and antisocial behavior in adulthood. Pediatrics 
2018;141(1):e20171703.
 18. Abreu  AP, Kaiser  UB. Pubertal development and regulation. 
Lancet Diabetes Endocrinol. 2016;4(3):254–264.
 19. Parent  AS, Teilmann  G, Juul  A, Skakkebaek  NE, Toppari  J, 
Bourguignon JP. The timing of normal puberty and the age limits 
of sexual precocity: variations around the world, secular trends, 
and changes after migration. Endocr Rev. 2003;24(5):668–693.
 20. The Municipality of Bergen. Levekår og helse i Bergen 2016. 
https://issuu.com/hg-9/docs/bg-kommune-levekarsrapport-
2016?e=19530043/41371289. Accessed March 18, 2020.
 21. Bruserud IS, Roelants M, Oehme NHB, et al. Supplemental tables, fig-
ures and figure legends. Figshare Digital Repository 2020. Deposited 
15 February 2020. doi:10.6084/m9.figshare.11858355.v1.
 22. Landis  JR, Koch GG. The measurement of observer agreement 
for categorical data. Biometrics. 1977;33(1):159–174.
 23. Cole  TJ, Bellizzi  MC, Flegal  KM, Dietz  WH. Establishing a 
standard definition for child overweight and obesity world-
wide: international survey. BMJ. 2000;320(7244):1240–1243.
 24. Cole TJ, Flegal KM, Nicholls D, Jackson AA. Body mass index cut 
offs to define thinness in children and adolescents: international 
survey. BMJ. 2007;335(7612):194.
 25. Wood S. Generalized Additive Models: An Introduction with R. 









niversitetsbiblioteket i Bergen user on 01 M
ay 2020
doi:10.1210/clinem/dgaa107 https://academic.oup.com/jcem  9
 26. Yüce Ö, Sevinç D. Ultrasonographic assessment of pubertal breast 
development in obese children: compliance with the clinic. J 
Pediatr Endocrinol Metab. 2018;31(2):137–141.
 27. Calcaterra V, Sampaolo P, Klersy C, et al. Utility of breast ultra-
sonography in the diagnostic work-up of precocious puberty and 
proposal of a prognostic index for identifying girls with rap-
idly progressive central precocious puberty. Ultrasound Obstet 
Gynecol. 2009;33(1):85–91.
 28. Carlson L, Flores Poccia V, Sun BZ, et al. Early breast develop-
ment in overweight girls: does estrogen made by adipose tissue 
play a role? Int J Obes (Lond). 2019;43(10):1978–1987.
 29. Brix N, Ernst A, Lauridsen LLB, et al. Timing of puberty in boys 
and girls: A population-based study. Paediatr Perinat Epidemiol. 
2019;33(1):70–78.
 30. Biro FM, Greenspan LC, Galvez MP, et al. Onset of breast develop-
ment in a longitudinal cohort. Pediatrics. 2013;132(6):1019–1027.
 31. Fredriks  AM, van  Buuren  S, Burgmeijer  RJ, et  al. Continuing 
positive secular growth change in The Netherlands 1955–1997. 
Pediatr Res. 2000;47:316–323.
 32. Mul  D, Fredriks  AM, van  Buuren  S, Oostdijk  W, Verloove-
Vanhorick SP, Wit JM. Pubertal development in The Netherlands 
1965–1997. Pediatr Res. 2001;50:479–486.
 33. Talma H, Schonbeck Y, van Dommelen P, Bakker B, van Buuren S, 
Hirasing RA. Trends in menarcheal age between 1955 and 2009 
in the Netherlands. PloS One 2013;8:e60056
 34. Brudevoll JE, Liestøl K, Walløe L. Menarcheal age in Oslo during 
the last 140 years. Ann Hum Biol. 1979;6(5):407–416.
 35. Juliusson  PB, Roelants  M, Eide  GE, Hauspie  R, Waaler  PE, 
Bjerknes  R. Overweight and obesity in Norwegian children: 
secular trends in weight-for-height and skinfolds. Acta Paediatrica. 
2007;96:1333–1337.
 36. Norwegian Institute of Public Health. Barn og overvekt. 
Folkehelserapporten 2017. https://www.fhi.no/nettpub/hin/
levevaner/overvekt-og-fedme/. Accessed January 21, 2020.
 37. Statistics Norway. Befolkning 05196: Statsborgerskap, alders- og 
kjønnsfordeling for hele befolkningen 1977–2019. Statistikkbanken 










niversitetsbiblioteket i Bergen user on 01 M
ay 2020
